BC

Broadfin Capital Portfolio holdings

AUM $403M
1-Year Est. Return 74.97%
This Quarter Est. Return
1 Year Est. Return
+74.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$274M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$34.1M
2
+$31.1M
3
+$21M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$20.1M
5
EBS icon
Emergent Biosolutions
EBS
+$18.5M

Top Sells

1
+$29.1M
2
+$23.4M
3
+$22.5M
4
NVDQ
Novadaq Technologies Inc.
NVDQ
+$16.6M
5
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$14.9M

Sector Composition

1 Healthcare 79.95%
2 Technology 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$4.81M 0.47%
+2
52
$4.72M 0.46%
+960
53
$4.63M 0.45%
+57,475
54
$4.61M 0.45%
+702,450
55
$4.36M 0.42%
784,893
56
$4.36M 0.42%
+121,867
57
$4.33M 0.42%
+263,204
58
$4.29M 0.42%
111,429
-64,285
59
$4.16M 0.4%
+26,042
60
$4.08M 0.4%
+224,234
61
$3.89M 0.38%
+57,882
62
$3.71M 0.36%
+263
63
$3.64M 0.35%
151,655
-575,000
64
$3.63M 0.35%
44,334
+11,001
65
$3.62M 0.35%
+300,000
66
$3.52M 0.34%
184,756
-29,530
67
$3.34M 0.32%
+53,752
68
$3.29M 0.32%
1,000,000
69
$3.24M 0.31%
+300,000
70
$3.09M 0.3%
1,424,796
+75,000
71
$3.06M 0.3%
+2,354
72
$3.02M 0.29%
+100,000
73
$2.97M 0.29%
+8
74
$2.9M 0.28%
9,177
-33,386
75
$2.69M 0.26%
+200,000
1 2
3
4